26th March 2020:   Research Paper Abstract:  The measurement of Vital Signs by Lifelight® software in comparison to standard of care – The VISION D Study

An Analysis of Lifelight First performance in real-world clinical use
Dr Melissa Kapoor – Mind Over Matter Medtech Limited

Vision D Abstract

BACKGROUND:
Lifelight First is a highly innovative technological solution for vital signs using the small colour changes recorded from the face by the camera in a standard smart device (e.g. smartphone or tablet) over 30-60 seconds. This report presents the results and conclusions from analysing data collected in the VISION D trial at Portsmouth Hospitals NHS Trust (PHT) to assess the safety and performance of Lifelight First on a large number of individuals, including those with abnormal vital signs, and in real-world clinical conditions.  Lifelight First has been developed by UK SME, xim Limited.

This report may be updated as future releases demonstrate improved performance. This is because Lifelight First uses Artificial Intelligence technology for the development of its algorithms, and the data collected from VISION D can be continuously re-analysed to allow continual optimisation.

Complete the short form below to receive the Abstract

Lifelight owned by xim Limited needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at anytime.

For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Notice.

26th March 2020:   Research Paper Abstract:  The measurement of Vital Signs by Lifelight® software in comparison to standard of care – The VISION D Study

An Analysis of Lifelight First performance in real-world clinical use
Dr Melissa Kapoor – Mind Over Matter Medtech Limited

BACKGROUND:
Lifelight First is a highly innovative technological solution for vital signs using the small colour changes recorded from the face by the camera in a standard smart device (e.g. smartphone or tablet) over 30-60 seconds. This report presents the results and conclusions from analysing data collected in the VISION D trial at Portsmouth Hospitals NHS Trust (PHT) to assess the safety and performance of Lifelight First on a large number of individuals, including those with abnormal vital signs, and in real-world clinical conditions.  Lifelight First has been developed by UK SME, xim Limited.

This report may be updated as future releases demonstrate improved performance. This is because Lifelight First uses Artificial Intelligence technology for the development of its algorithms, and the data collected from VISION D can be continuously re-analysed to allow continual optimisation.

Complete the short form below to receive the Abstract

Lifelight owned by xim Limited needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at anytime.

For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Notice.

26th March 2020:   Research Paper Abstract:  The measurement of Vital Signs by Lifelight® software in comparison to standard of care – The VISION D Study

An Analysis of Lifelight First performance in real-world clinical use
Dr Melissa Kapoor – Mind Over Matter Medtech Limited

BACKGROUND:
Lifelight First is a highly innovative technological solution for vital signs using the small colour changes recorded from the face by the camera in a standard smart device (e.g. smartphone or tablet) over 30-60 seconds. This report presents the results and conclusions from analysing data collected in the VISION D trial at Portsmouth Hospitals NHS Trust (PHT) to assess the safety and performance of Lifelight First on a large number of individuals, including those with abnormal vital signs, and in real-world clinical conditions.  Lifelight First has been developed by UK SME, xim Limited.

This report may be updated as future releases demonstrate improved performance. This is because Lifelight First uses Artificial Intelligence technology for the development of its algorithms, and the data collected from VISION D can be continuously re-analysed to allow continual optimisation.

Complete the short form below to receive the Abstract

Lifelight owned by xim Limited needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at anytime.

For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Notice.